2025 HIMSS Global Health Conference & Exhibition
This year’s event brings an exciting array of new features designed to empower attendees with the latest tools, trends, and strategies. From cutting-edge digital health solutions to immersive experiences in AI, interoperability, and smart health, the event will showcase breakthroughs that are shaping the future of care delivery. HIMSS25 is set to redefine the landscape of healthcare technology and innovation.
Session information:
Panel session: Revolutionizing Drug Development Through Strategic and Evidence-Driven Digital Health Innovations
Track: General Education – Technology
Date: Thursday, March 6, 2025
Time: 9:45 a.m- 10:45 a.m. PST
Abstract:
Digital Health Technologies (DHTs) are currently being implemented in drug development and healthcare settings, ranging from regulatory endorsed to innovative exploratory technological development. As advancements in sensing technologies and their verified and validated use in effective clinical decision-making progress along with the necessary infrastructure to support their integration, we can expect a streamlined and more efficient integration of DHTs across various stages of drug development. This will support areas such as population identification/stratification, dose selection, collection of real-world data and real-world evidence, evidence for effectiveness and safety, and disease management.
This session will include a panel discussion to help the audience gain a better understanding of existing applications and opportunities for DHTs in drug development and important considerations for their validation and/or endorsement by regulatory agencies depending on the development stage. The talks will explore diverse technological advancements within DHTs and their utilization across various stages and processes in drug development. Furthermore, we will delve into the synergistic use of DHTs in drug development and clinical care settings.
Speaker
Kristen Sowalsky, Ph.D., D.C.
VP, Medical & Scientific Affairs, Precision Motion at Clario
Dr. Kristen Sowalsky is the Vice President of Medical & Scientific Affairs for Precision Motion at Clario. She oversees the scientific advisory, data science and biostatistical services for digital measures of human movement in clinical trials and academic research. Dr. Sowalsky has 18 combined years of experience in industry, academic/clinical research and clinical practice. Her academic achievements include a BS in Kinesiology and Exercise Science from Appalachian State University, a Doctor of Chiropractic from Logan University and a Ph.D. in Applied Neuromechanics from the University of Florida. Dr. Sowalsky is also a member of the University of Florida Industry Board. Passionate about improving the lives of patients and their families, Dr. Sowalsky aims to advance meaningful digital mobility outcome utilization to inform therapeutic innovation and development.